FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/09/046004 [Registered on: 28/09/2022] Trial Registered Prospectively
Last Modified On: 07/11/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study
Modification(s)  
A comparative clinical study to evaluate the efficacy of Ayurvedic Dentifrices in providing dental protection  
Scientific Title of Study
Modification(s)  
A comparative clinical study to evaluate the efficacy of Ayurvedic Dentifrices in providing dental protection  
Trial Acronym  NA 
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
ORAL/DADM/2022-04; version 2.0; Date 28 October 2022  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Lakshmi Chandrasekaran 
Designation  Principal Investigator - MDS 
Affiliation  MS Clinical Research Pvt. Ltd 
Address  327/15, 1st Main Road, Cambridge layout Ulsoor

Bangalore
KARNATAKA
560008
India 
Phone  918040917253  
Fax  918041125934  
Email  lakshmi@mscr.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sasibhushan Vedula 
Designation  Head - Medical Affairs and Clinical Research 
Affiliation  Dabur Research and Development Centre 
Address  Plot No.22, Site IV, Sahibabad

Ghaziabad
UTTAR PRADESH
201010
India 
Phone  01204378405  
Fax  01204552645  
Email  sasibhushan.vedula@dabur.com  
 
Details of Contact Person
Public Query
 
Name  Ritambhara 
Designation  Director 
Affiliation  MS Clinical Research Pvt. Ltd 
Address  327/15, 1st Main Road, Cambridge layout Ulsoor

Bangalore
KARNATAKA
560008
India 
Phone  918040917253  
Fax  918041125934  
Email  ritambhara@mscr.in  
 
Source of Monetary or Material Support  
Dabur Research and Development Centre Dabur India Limited Plot No.22, Site IV, Sahibabad-201010, Ghaziabad (U.P.), India 
 
Primary Sponsor  
Name  Dabur India Limited 
Address  8/3, Asaf Ali Road, New Delhi, India 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Lakshmi Chandrasekaran MDS  MS Clinical Research Pvt. Ltd  327/15, 1st Main Road Cambridge layout, Ulsoor
Bangalore
KARNATAKA 
918040917253
918041125934
lakshmi@mscr.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Clinicom  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K088||Other specified disorders of teethand supporting structures. Ayurveda Condition: DANTAGATAROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Marketed White Toothpaste(1) Medicine Name: Marketed White Toothpaste, Route: Oral, Dosage Form: Toothpaste, Dose: 2-3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 days, anupAna/sahapAna: No
2Intervention ArmDrugOther than Classical(1) Medicine Name: Ayurvedic Dentifrice Tooth Paste, Reference: NA, Route: Oral, Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Approx. 2-3 g of Ayurvedic Dentifrice Tooth Paste
3Intervention ArmDrugOther than Classical(1) Medicine Name: Ayurvedic Dentifrice Herbal Tooth Powder, Reference: NA, Route: Oral, Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: approx. 1-1.5g of Ayurvedic Dentifrice Herbal Tooth Powder
4Intervention ArmDrugOther than Classical(1) Medicine Name: Ayurvedic Dentifrice sprinkled over marketed white toothpaste, Reference: NA, Route: Oral, Dosage Form: Dantamanjan Churna/ Gum Paint, Dose: 50(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Ayurvedic Dentifrice (approx. 50 mg) will be sprinkled over Marketed white tooth Paste (2-3 g)
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1.Male and female subjects in age group 18 – 55 years (both the ages inclusive).
2.Having at least 16 natural, permanent teeth.
3.Subjects with poor dental hygiene (self-reported and clinically diagnosed)
4.Subjects who have plaque and dental caries. (Caries score up to 2 using International Caries Detection and Assessment System (ICDAS).
5.Subjects with extrinsic dental stains (Score up to 2 using Lobene Stain Index)
6.Subjects willing to give their oral swab samples for analysis.
7.Subjects willing to come for follow up visits at the specified time.
8.Subjects ready to follow study related procedures during the study period.
9.Subject able to read, understand and sign an appropriate informed consent form indicating willingness to participate.
 
 
ExclusionCriteria 
Details  1.A known history or present condition of hypersensitivity to any toothpaste and tooth powder
2.Subjects taking any supplementation known to support teeth health which may interfere study results.
3.The use of antibiotic, analgesic medications, mouthwash or desensitizing toothpaste during the previous 1 month.
4.Any history of periodontal therapy by surgical interventions.
5.Subjects with active periodontal conditions.
6.Subjects who have used any medicated/fluoridated toothpastes.
7.Orthodontic treatment with fixed appliances.
8.Any removable device such as a removable partial denture or orthodontic retainer.
9.The presence of any fixed appliance, large or defective restorations, cracked enamel,
10.Subjects who have a history of smoking or use smokeless tobacco products/betel chewing
11.Subjects who are pregnant or lactating
12.Subjects having severe level of calculus and/ tartar.
13.Any underlying systemic illnesses, medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, a positive HIV status, hepatitis etc. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Improvement in teeth health basis dental examination (Teeth surface, Plaque and Caries) with regular use of study product in comparison to the baseline and with White toothpaste
2. Improvement in gum health (colour, consistency, gum bleeding) as per the dental examination (Gingiva) with regular use of study product in comparison to the baseline and with White toothpaste 
Day 1 and Day 30 
 
Secondary Outcome  
Outcome  TimePoints 
•Reduction in teeth stains
•Reduction in malodour causing bacteria
•Improvement in teeth colour
•Reduction in Plaque Index.
•Reduction in halitosis basis VSC (Volatile Sulphur Compounds) scores (Oral chroma)
•Reduction in gingival index
•Change in Teeth colour using Vita Shade Guide assessment and Image analysis.
•Reduction in Lobene stain index
-Demineralization of teeth using Imaging in
comparison to the baseline and with comparator product (exploratory) 
Day 1 and day 30 
 
Target Sample Size
Modification(s)  
Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)
Modification(s)  
16/11/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This will a comparative study to evaluate the effect of Ayurvedic Dentifrices in providing dental protection in comparison to the baseline and/or white toothpaste. There will be four arms in the study. A total of 140 subjects (35 in each group to get minimum 30 completers ) will be enrolled. Study intervention period will be of one month. Results will be analyzed using suitable statistical methods.  
Close